Is KalVista Pharmaceuticals, Inc. (KALV) a Buy, Sell, or Hold?
NASDAQ : KALV
KalVista Pharmaceuticals, Inc.
$27 USD
$0 (0.0%)
- Volume
- 4.26M
- Average Volume
- 3.54M
- Market Capitalization
- $1.44B
- P/E Ratio
- -8.36
- Dividend Yield
- 0.00%
- Price Target
- $27.00
- Year High
- $27.00
- Year Low
- $9.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.58
Analyst Consensus Summary
Consensus Rating
N/A
13 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
0.0%
vs Current Price
Price Target
$27.00
Average TargetPrice Target Range
Lowest Target
$27.00
0.0% UPSIDE
Average Target
$27.00
Median Estimate
Highest Target
$27.00
0.0% UPSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 11 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Andrew Fein | $27 | $26.66 | 2026-05-01 06:05 AM | 1.3% |
| H.C. Wainwright | Andrew Fein | $37 | $15.82 | 2026-01-09 06:09 AM | 133.9% |
| Needham | Serge Belanger | $28 | $11.25 | 2024-11-05 07:09 AM | 148.9% |
| H.C. Wainwright | Andrew Fein | $20 | $12.87 | 2024-09-06 02:54 AM | 55.4% |
| Leerink Partners | Joseph Schwartz | $20 | $12.87 | 2024-09-06 02:35 AM | 55.4% |